Original Research

Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study

Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T

Research and Reports in Urology 2026, 18:612372

Published Date: 5 June 2026